Razael wrote:It will be interesting when it comes out as a monotherapy
pharma is only interested in patenting compounds so they are developing drugs that will appeal to psychiatrists before sarcosine will that does exactly the same thing.
can't wait to try it, supposed to e good for cognitive, negative symptoms [if there is any at least apparently it will help with the neuroleptic induced symptoms, side effects that are considered typical schizophrenia symptoms]....
It helps with treatment resistant people mostly for positive and negative symptoms
Users browsing this forum: Google Adsense [Bot], Johnny5 and 59 guests